Contact Us

EU Commission

Q&A Published by the EU Commission Regarding Information Obligation In Case of Interruption or Discontinuation of Supply of Certain Medical Devices or In-Vitro Diagnostic Devices

by

The EU Commission has released a Q&A document regarding the Information Obligation in Case of Interruption or Discontinuation of Supply of Certain Medical Devices or In-Vitro Diagnostic Devices, a measure first introduced in the amendment (EU) 2024/1860. To offer some background to this document, earlier this year, an amendment to the IVDR and MDR, dubbed … Read more

EU Parliament Vote to Revise MDR and IVDR

by

The EU Parliament has adopted a resolution to revise the MDR and IVDR to address the ongoing challenges regarding implementation and support patient access to essential medical devices by 2025. The EU Parliament’s proposed amendments to the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) are timely, balancing much-needed reform with a commitment … Read more

EU Commission Release Report from Study Conducted Regarding the Implementation of Article 17 of Regulation (EU) 2017/745 on medical devices on the EU market

by

The EU Commission has released a report from a study that they have conducted concerning the reprocessing and reuse of single-use-devices in the EU. The study aimed to evaluate how the provisions that have been established in Article 17 of the MDR, which regulates the reprocessing of Single Use Devices (SUD’s), have been implemented and … Read more

Two Commission Implementing Decisions with References of Harmonised Standards Have Been Published.

by

On March 8th 2024 the EU Commission published in the Official Journal of the European Union (OJEU) two Commission implementing decisions concerning new references of harmonised standards in support of Regulation (EU) 2017/745 on medical devices (MDR) and of Regulation (EU) 2017/746 (IVDR). For the MDR: Commission Implementing Decision (EU) 2024/815 of 6 March 2024, … Read more

EU Commission Proposes IVDR Extension

by

The introduction of the IVDR came with very substantial regulatory changes to the regulatory framework for IVD’s. One of the most significant changes is the increased involvement of independent notified bodies for the conformity assessment that is proportionate to the classification of the device. Under the IVDD, only a small number of high-risk devices equating … Read more

EU Commission Proposes Gradual EUDAMED Rollout

by

The EU commission is proposing making some of the EUDAMED modules mandatory at an earlier stage, by Quarter 4 of 2025. Under the current legislation, EUDAMED will become mandatory when all 6 modules are functional, which due to some delays in the development of the module for clinical investigations/performance studies, would be late 2029. Under … Read more

The European Commission’s Directorate-General for Health and Food Safety has published MDR and IVDR Language Requirements for Manufacturers.

by

The EU is made up from 27 countries, most of them having their own national language. Since there is no official language of the European Union, each member state has different requirements that would need to be respected when making a device available in a particular member state. The MDR and IVDR both contain legal … Read more

EU Commission Release Information on the Applications for Designation as a Notified Body

by

The EU Commission have released an overview of CAB/NBs at each stage of the designation process. The document shows the different stages of the designation process and how many organisations passed each stage. The data shows that a total of 21 and 62 organisations have lodged applications SANTE F for the IVDR and MDR respectively. … Read more

The EU Commission Has Commissioned a Study Monitoring the Availability of Medical Devices on the EU Market

by

The study is focusing on two key stakeholder groups, manufacturers and authorised representatives. The outcome of which, is to effectively monitor the availability of medical devices (including in-vitro diagnostic devices) on the EU market and the insights from these two key stakeholders are deemed essential. This study will be conducted repeatedly over a three year … Read more

MDR and IVDR Communication Survey

by

The EU Commission published a survey in August 2023, this survey is due to close by the end of November 2023. It is only intended for stakeholders who are directly impacted by the regulatory changes for medical devices. That would seem to be a great number of organisations. The object of this survey is to … Read more

+ More
13485_SGQ-MED_sg04

Advena Ltd

Registered Address:
Tower Business Centre
2nd Flr, Tower Street Swatar,
BKR 4013. Malta
Reg. in Malta No. C 76865

Advena Services Ltd

Registered Address:
Tower Business Centre
2nd Flr, Tower Street Swatar,
BKR 4013. Malta
Reg. in Malta No. C 103067

Advena Malta (Holdings) Ltd

Registered Address:
Highdown House
Leamington Spa, CV31 1XT,
United Kingdom.
Reg. in the UK No. 13789474

Advena SRL

Registered Address:
Via Visconti di Modrone 38
20122 Milan
Italy
Company No: MI-2785259

Reach out for a consultation.

EU Authorised Representative, Regulatory & Quality Consultants for Medical Devices

Contact Us

Quick Links

Contact

+356 2546 6689

info@advenaltd.eu

Contact Us

Connect

© 2026 Advena Ltd

Privacy Policy Terms of Service

Proudly designed by </encode>

Advena.mt Logo Website
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.